COAGVSSLS• Today (Normalized)
COAG vs SLS (Hemab Therapeutics Holdings Inc. vs SELLAS Life Sciences Group Inc.)
Showing Closing Date Range from Sep, 10 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
COAG Performance $39.4
-1.2%
Hemab Therapeutics Holdings Inc.
Normalized Baseline0.00%
SLS Performance $11.55
-14.42%
SELLAS Life Sciences Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin COAG LEADS
+13.22%
COAG outperforming by 13.22%
COAGSLS
Spread TrajectoryToday (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
COAG SLS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(2 dates)
| Date | COAG Price | COAG Gain (%) | SLS Price | SLS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $39.40 | -1.20% | $11.55 | -14.42% | +13.22% |
| Sep 10, 2026 | $39.88 | +0.00% | $13.49 | +0.00% | +0.00% |